Solid Biosciences (SLDB) Non Operating Income (2017 - 2026)
Solid Biosciences' Non Operating Income was $2.59 million in Q2 2026, up 16.8% from $2.21 million a year earlier and up 352.7% from the prior quarter.
Solid Biosciences (SLDB) Non Operating Income (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Solid Biosciences' Non Operating Income was $5.05 million through Jun 30, 2026, up 84.5% year-over-year; for FY2025, it was $4.88 million, down 3.0% from FY2024.
- Non Operating Income has now declined for three consecutive years, though with a five-year compound annual growth rate of 111.3% (FY2020 to FY2025).
- In earlier years, Non Operating Income was $5.03 million in FY2024 (-38.9%), $8.24 million in FY2023 (-59.8%), $20.47 million in FY2022 and $66,000 in FY2021 (-43.1%).
- The Q2 2026 figure marks the highest quarterly Non Operating Income since Q2 2024.
- Compared with a year earlier, Non Operating Income was higher in two of the last six quarters, with an average decline of 14.9%.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2023 (growth of 663.4%); the worst was Q4 2023 (a decline of 90.1%).
- Per Business Quant data, SLDB's Non Operating Income in the three quarters before Q2 2026 was $571,000 (Q1 2026), -$384,000 (Q4 2025) and $2.28 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Solid Biosciences | 1.08 Bn | -212.24 Mn | - | 3.71 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.71 Mn |
| Jun 30, 2026 | 2.59 Mn |
| Mar 31, 2026 | 571,000.00 |
| Dec 31, 2025 | -384,000.00 |
| Sep 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | 770,000.00 |
| Dec 31, 2024 | -2.70 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.72 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 19.42 Mn |
| Sep 30, 2022 | 722,000.00 |
| Jun 30, 2022 | 290,000.00 |
| Mar 31, 2022 | 44,000.00 |
| Dec 31, 2021 | 42,000.00 |
Solid Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SLDB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();